Hong Kong’s Regencell Bioscience triples in latest surge for a speculative stock
Hong Kong SkylineNikada | E+ | Getty PicturesRegencell Bioscience Holdings, an early-stage, Hong Kong-based bioscience firm with no income, is the most recent speculative abroad inventory to draw an uncommon ...
